We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Combining NGS Technologies for Biomarker Identification and Confirmation Research

Advances in next-generation sequencing (NGS) technologies have fuelled efforts to identify molecular markers of disease. By combining multiple targeted NGS strategies, it is possible to characterize biomarkers in areas such as cancer, helping to monitor disease progression.

Download this app note to discover:

  • Two targeted NGS methods that can identify and confirm biomarkers in germline and somatic mutations
  • The benefits and caveats of different NGS approaches
  • The potential of circulating tumor DNA as a non-invasive method to screen and monitor disease progression